Search

Orthocell considers IPO push

Biotech player Orthocell has appointed two financial advisory firms to seek out investors as part of the company’s plans to go public.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Orthocell (OCC)

Share Price

Closing price for the last 90 trading days
Source: Morningstar

Total Shareholder Return as at 31/01/18

1 year TSR5 year TSR
262ndPeppermint Innovation36%-30%
551stEphraim Resources-16%-15%
587thOrthocell-21%0%
695thVolt Power Group-40%-13%
801stTikForce-72%-50%
709 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

24/11/17
$0 Other
24/11/17
$0 Other
24/11/17
$0 Other
Total value as at the date of the transaction
Source: Morningstar

Revenue

146th↑Ephraim Resources$1.1m
147th↓Volt Power Group$1.1m
148th↓Orthocell$1.0m
149th↓Peppermint Innovation$1.0m
150th↑TikForce$1.0m
234 listed industrial companies ranked by revenue.
Source: Morningstar

Remuneration from Orthocell

284thPaul Anderson$438k
823rdStewart Washer$150k
924thMatt Callahan$120k
Ranked by total remuneration from all listed WA companies

BNiQ Disclaimer